Preeclampsia and pathology of placentation

Abstract

Etiology of pre-eclampsiaremainsunclear. However, it is recognized that genetic factors of both mother’s and father’s sides can determine the development of this awesome complication of pregnancy. The interplay of genetic factors with external influences determines the risk level of pre-eclampsia. Today it is reasonable to assert that pre-eclampsia is a complication of pregnancy associated with the disturbances of the process of trophoblast invasion and changes in haemodynamics in spiral arteries. The process of trophoblast invasion proved to be coordinated by combined interaction of cytokines, factors of adhesion and different growth factors.
Functional abnormalities of endothelium of placental and pre-placental vessels may be a result but not a cause of development ofpre-eclampsia, pathophysiology of which is studied still insufficiently. However, the disturbance оf NO, endothelein release and thrombocytes homeostasis as well are certain to be the main manifestations of this pregnancy complication. A fter revealing all the mechanisms of process of trophoblast invasion disturbances an actual possibility of early prevention and treatment of pre-eclampsia may be elaborated.

Keywords

theory of etiopathogenesis of preeclampsia / implantation and placentation processes

References

[1] Arbogast В. W., Leeper S.С., Merrick R.D., Olive К. Е., Taylor R.N. Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet, 1994; 343:340-1.

[2] Arngrimsson R., Bjornsson H., Geirsson R. Analysis of different inheritance patterns in pre- eclalmpsia / eclampsia syndrome. Hypertension Pregnancy, 1995; 14:27-38.

[3] Austgulen R., Lien E., Vince G., Redman C. W. G. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E- selectin) in preeclampsia. Eur. J.

[4] Obstet. Gynecol. Reprod. Biol. 1997; 71: 53-8.

[5] Beckman L.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Nati. Acad. Sci.: USA, 1990; 87: 1620-4.

[6] Burrows T.D., King A., Loke Y.W. Expression of adhesion molecules by vascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta, 1994; 15:21- 33.

[7] Chesley L.C. Hypertensive disorders in pregnancy. New York: ЖУРНАЛЪ Appleton-Century-Crofts, 1978.

[8] Cooper J. C., Sharkey A. M., Charnock-Jones D.S., Palmer C.P., Smith S. K. VEGF mPNA levels in placentae from pregnancies complicated by preeclampsia. Br. J. Obstet. Gynaecol., 1996; 103:1191 -6.

[9] Darling M. Low-dose aspirin not for pre-eclampsia. Lancet, 1998;

[10] 352:342.

[11] Entman S.S., Richardson L.D. Clinical applications of the altered iron kinetics of toxemia of pregnancy. Am. J. Obstet. Gynecol., 1983; 146:568.

[12] Erkkola R. Can preeclampsia be predicted and prevented? Acta Obstet. Gynecol. Scand., 1997; Suppl. 164:98-100.

[13] Genbacev 0., Zhou Y., LudJow J.W., Fisher S. J. Regulation of human placental development by oxygen tension. Science, 1997; 277:1669-72.

[14] Harlan J.D. Neutrophil-mediated vascular damage. Acta Med. Scand., 1987: Suppl. 715: 123-9.

[15] Poranen A.-K., Ekblad U., Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta, 1996; 17:401-5.

[16] Roberts J. M., Redman C.W.G. Pre-eclampsia: more than pregnancy induced hypertension. Lancet, 1993; 341: 1447-54.

[17] Shimonowitz S., Hurwitz A., Dushnik M., Adashi E. Y., Anteby E., Yagel S. Cytokine-mediated regulation of type IV collagenase expression and production in human trophoblastic cells. J. Clin.

[18] Endocrinol. Metab., 1996; 81: 3091- 6.

[19] Thornton J. G., Onwude J.L. Pre- eclampsia: discordance among identical twins. BMJ, 1991; 303: 1241-2.

[20] Vigne J. L., Murai J. T., Arbogast B.W., Jia W., Fisher S. J., Taylor R.N. Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J. Clin. Endocrinol. Metab., 1997; 82: 3786-92.

[21] Vince G. S., Starkey P.M., Austgulen R., Kwiatowski D.,

[22] Redman C.W.G. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br. J. Obstet. Gynaecol., 1995; 102: 20-5.

[23] Wang Y., Walsh S.W. Aspirin inhibits both lipid peroxides and throm-boxane in preeclamptic placentas. Free Radic. Biol. Med., 1995; 18:585-91.

[24] Zhou Y., Damsky C.H, Fisher S J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome. J. Clin. Invest. 1997(b); 99: 2152-64.

[25] Zhou Y., Fisher S.J., Janatpour M. et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion. J. Clin. Invest. 1997(a); 99: 2139-51.

[26] Harrison G.A, Humphrey K.E., Jones N., et al. A genomewide linkage study of preeclampsia / eclampsia reveals evidence for a candidate region 4q. Am. J. Hum. Genet., 1997; 60: 1158-67.

[27] Hayward C., Livingstone J., Holloway S., et al. An exclusion map for pre-eclampsia: assuming an autosomal recessive inheritance. Am. J. Hum. Genet. 1992: 0: 749-57.

[28] Knight M.; Redman C.W.G., Linton E.A., Sargent I.L. Shedding of syncytiotrophoblast microvilli into maternal circulation in pre-eclamptic pregnancies. Br. J. Obstet.

[29] Gynaecol., 1998; 105: 632-40.

[30] Lie R.T., Rasmussen S., В run bo rg H., Gjessing H.K., Lie-Nielsen E., Irgens L.M. Fetal and maternal contributions to risk of preeclampsia: population based study. BMJ, 1998; 316: 1343-7.

[31] Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br. J. Obstet. Gynaecol., 1997; 104: 223-8.

[32] McMasterM.T., Librach C.I., Zhou Y., et al. Human placental HLA- G expression is restricted to differentiated cytotrophoblasts. J. Immunol., 1995; 154: 3771-8.

[33] Meekins J.W., Pijnenborg R., Hanssens M., McFadyen LR., van Asschc A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br. J. Obstet. Gynaecol., 1994; 101: 669- 74.

[34] Morris N.H., Eaton B.M., Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br. J. Obsret. Gynecol., 1996; 103:4-15.

[35] Myatt L., Rosenfeld R.B., EisA.L., Brockman D.E., Greer I., Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996; 28: 488-93.

[36] Makila U.M., Ylikorkala 0. Prostaglandiinit ja tromboksaani raskau-den aikana. Duodecim, 1984; 100: 1065-71.

[37] Pijnenborg R., McLaughlin P.J., Vercruysse L., Hanssens M., John¬son P.M., Keith Jr.J.C., Van Asschc F.A. Immunolocalization of tumour necrosis factor-а (TNF-a) in the placental bed of normotensive and hypertensive human pregnancies. Placenta: 1998: 19:231-9.

RIGHTS & PERMISSIONS

Eсо-Vector